Abstract
Antibiotic prophylaxis has been used for several decades to prevent infection in chemotherapy-induced neutropenia and its benefits have been debated just as long. Recent analysis suggests that quinolones may actually be life saving in high-risk groups such as acute leukaemia and autologous bone marrow transplant but these benefits are likely to be negated in the long term by the development of quinolone resistance.
Original language | English |
---|---|
Pages (from-to) | 60-65 |
Number of pages | 6 |
Journal | International Journal of Antimicrobial Agents |
Volume | 30 |
Issue number | SUPPL. 1 |
DOIs | |
Publication status | Published - Nov 2007 |
Keywords
- Antibacterial prophylaxis
- Cancer
- Leukaemia
- Quinolones
ASJC Scopus subject areas
- Applied Microbiology and Biotechnology
- Microbiology
- Parasitology
- Virology
- Immunology and Allergy
- Infectious Diseases